We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Chinese, Indian API Makers Eyeing EU Markets Forced to Fine-Tune GMPs
Chinese, Indian API Makers Eyeing EU Markets Forced to Fine-Tune GMPs
May 17, 2013
Both China and India are working to help makers of active pharmaceutical ingredients (API) satisfy the tough, new quality requirements in the EU’s Falsified Medicines Directive before the directive’s July 2 deadline.